RYTCX
Price
$8.03
Change
+$0.05 (+0.63%)
Updated
Jul 25 closing price
Net Assets
948.59M
VSIAX
Price
$87.39
Change
+$0.46 (+0.53%)
Updated
Jul 25 closing price
Net Assets
55.61B
Interact to see
Advertisement

RYTCX vs VSIAX

Header iconRYTCX vs VSIAX Comparison
Open Charts RYTCX vs VSIAXBanner chart's image
Royce Small-Cap Total Return Consult
Price$8.03
Change+$0.05 (+0.63%)
VolumeN/A
Net Assets948.59M
Vanguard Small Cap Value Index Admiral
Price$87.39
Change+$0.46 (+0.53%)
VolumeN/A
Net Assets55.61B
RYTCX vs VSIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
RYTCX vs. VSIAX commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RYTCX is a Hold and VSIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSIAX has more cash in the bank: 55.6B vs. RYTCX (949M). VSIAX pays higher dividends than RYTCX: VSIAX (2.11) vs RYTCX (1.44). RYTCX was incepted earlier than VSIAX: RYTCX (24 years) vs VSIAX (14 years). RYTCX (2.24) is less costly to investors than VSIAX (0.07). RYTCX is a more actively managed with annual turnover of: 51.00 vs. VSIAX (16.00). RYTCX has a lower initial minimum investment than VSIAX: RYTCX (2000) vs VSIAX (3000). VSIAX annual gain was more profitable for investors over the last year : 5.59 vs. RYTCX (-2.57). VSIAX return over 5 years is better than : 88.99 vs. RYTCX (-12.46).
RYTCXVSIAXRYTCX / VSIAX
Total Expense Ratio2.240.073,200%
Annual Report Gross Expense Ratio2.240.073,200%
Fund Existence24 years14 years-
Gain YTD-0.2482.904-9%
Front LoadN/AN/A-
Min. Initial Investment2000300067%
Min. Initial Investment IRAN/AN/A-
Net Assets949M55.6B2%
Annual Yield % from dividends1.442.1168%
Returns for 1 year-2.575.59-46%
Returns for 3 years2.3431.088%
Returns for 5 years-12.4688.99-14%
Returns for 10 years-42.65102.83-41%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BBIO46.280.62
+1.36%
BridgeBio Pharma
VIRT44.200.43
+0.98%
Virtu Financial Inc
NYMTN21.61N/A
N/A
New York Mortgage Trust
ARCT14.94-0.01
-0.07%
Arcturus Therapeutics Holdings
CELU2.96-0.20
-6.33%
Celularity